Preemption (FDA & Products Liability)

Medtronic, Inc. v. Lohr — Study Notes

Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996)

Study notes for Medtronic, Inc. v. Lohr: professor notes, cold call prep, exam angles, and memory aids.

State common-law claims against a §510(k)-cleared medical device are not categorically preempted by federal law.
Professor Notes

This case is pivotal in understanding the interaction between federal regulation and state products liability claims. The Supreme Court clarified that the Medical Device Amendments of 1976 do not categorically preempt state tort claims against medical device manufacturers, particularly those asserting design defects, manufacturing flaws, and failure to warn. The Court emphasized that the mere clearance of a device through the FDA’s §510(k) process does not create extensive federal regulatory standards that would lead to preemption of state law, thereby allowing for continued reliance on state liability laws to protect consumers.

Students should focus on the implications of this decision for future cases involving medical devices. The ruling illustrates the ongoing tensions between federal oversight and state authority in managing product safety, particularly in light of evolving technologies and the FDA's varied clearance processes. It's also essential to understand how this determination influences the strategic decisions of both plaintiffs and defendants in related litigation.

Cold Call Prep
  1. 1Explain the significance of the §510(k) process in this case.
  2. 2What are the implications of the Court's holding for future design-defect claims?
  3. 3How did the Court distinguish between the PMA and §510(k) processes?
  4. 4Discuss the types of claims that may avoid preemption under the Court's ruling.
  5. 5What evidence did the Lohrs present to support their claims against Medtronic?
  6. 6How does this case illustrate the balance between federal and state law?
Mnemonic Device

Lohr's Lead Lifts Liability: §510(k) Doesn't Shield.

Distinguish From
CaseDistinction
Riegel v. Medtronic, Inc.Riegel involved a PMA-approved device where the Court found broad preemption of state law claims, contrasting with Lohr’s focus on §510(k)-cleared devices.
Wyeth v. LevineWyeth addressed preemption in the pharmaceutical context, highlighting different regulatory standards compared to medical devices and emphasizing that failure-to-warn claims could coexist with federal regulations.
Policy Arguments

For the Rule

Allowing state law claims promotes accountability and encourages manufacturers to ensure product safety beyond federal requirements.

Against the Rule

Preemption is necessary to maintain uniformity in the regulation of medical devices and to prevent the burden of varying state laws on manufacturers.

Class Discussion Points
  • The role of the FDA in balancing public safety versus innovation in medical devices.
  • Real-world implications of preemption on patient safety and manufacturer liability.
  • Judicial interpretation of federal statutes concerning their scope and purpose in the context of medical devices.
Exam Angle

This case often appears in exams as a discussion on the scope of preemption regarding state product liability claims, particularly within the context of FDA regulation. Be prepared to analyze the impact of federal standards on state law questions.

View Full Case Brief

Ace Your Cold Calls with Briefly

Get AI-powered case briefs, study notes, and cold call prep for every case in your casebook.